{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:17:35Z","timestamp":1697260655093},"reference-count":13,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2007,8,10]],"date-time":"2007-08-10T00:00:00Z","timestamp":1186704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Inflammatory and\/or immune activation occurs both in animal models (twitcher mice) and in the brain of patients with Globoid cell leukodystrophy (GLD) or Krabbe's disease (KD). In this study we evaluated <jats:italic>in vitro<\/jats:italic> the cytokine profile of KD patients and the effect of psychosine, the toxic metabolite which plays a role in the demyelination process in these patients.<\/jats:p><jats:p><jats:bold>Materials and methods\u2002<\/jats:bold> We studied cytokine production by peripheral blood mononuclear cells (PBMCs) isolated from four KD patients, diagnosed on the basis of clinical criteria. Cells were cultured and stimulated with appropriate agents and the supernatants collected before and after the addition of psychosine. Tumour necrosis factor\u2010alpha (TNF\u2010\u03b1), interleukin\u20108 (IL\u20108) and monocyte chemoattractant factor (MCP)\u20101) production was evaluated (ELISA method) and compared with a group of 10 normal subjects.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> We found a significant increase of TNF\u2010\u03b1 release by PBMCs of KD patients compared with healthy subjects; TNF\u2010\u03b1 production was significantly increased after LPS addition. Psychosine was able to induce a further significant increase (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00\u00b705) only in cells obtained from KD patients and not from control subjects. No changes were found in IL\u20108 and MCP\u20101 production.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The increased TNF\u2010\u03b1 production permits us to confirm the presence of an inflammatory\u2010immune stimulus in KD patients, which may be induced and potentiated by the pathogenetic metabolite psychosine.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2007.01850.x","type":"journal-article","created":{"date-parts":[[2007,8,11]],"date-time":"2007-08-11T08:33:30Z","timestamp":1186821210000},"page":"742-745","source":"Crossref","is-referenced-by-count":11,"title":["Increased TNF\u2010\u03b1 production by peripheral blood mononuclear cells in patients with Krabbe's disease: effect of psychosine"],"prefix":"10.1111","volume":"37","author":[{"given":"A. L.","family":"Pasqui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Di Renzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Auteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Puccetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,10]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"187","volume-title":"Neurodystrophies and Neuropathy (Revised","author":"Kolodny EH","year":"1996"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-73697-1_37"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2005.07.016"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(96)00166-X"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0387-7604(02)00057-8"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1044-7431(03)00218-5"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.24.11294"},{"key":"e_1_2_5_9_2","unstructured":"PedchenkoTV BronshteynIG LeVineSM.TNF\u2010receptor 1 deficiency fails to alter the clinical and pathological course in mice with globoid cell leukodystrophy (twitcher mice) but affords protection following LPS challenge."},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20529"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2005.08.004"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0798com"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/82.1.25"},{"key":"e_1_2_5_14_2","volume-title":"Test Revision","author":"APA","year":"2000"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2007.01850.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2007.01850.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T13:37:34Z","timestamp":1697204254000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2007.01850.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,10]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1111\/j.1365-2362.2007.01850.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2007.01850.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,10]]}}}